Results 211 to 220 of about 150,674 (263)

Lyophilised colourimetric LAMP for visual readout with dual colour indicators.

open access: yesAnalyst
Malpartida-Cardenas K   +4 more
europepmc   +1 more source

Advances in the management of TTP

Blood Reviews, 2022
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unrecognised and untreated. The hallmark is thrombocytopenia and microangiopathic hemolytic anemia, with a blood film characterised by fragmented red cells and end organ damage.
M, Subhan, M, Scully
openaire   +2 more sources

ADAMTS13 and TTP

Current Opinion in Hematology, 2002
Thrombotic thrombocytopenic purpura (TTP) has been a mysterious and deadly disease that often could be treated effectively by plasma exchange, but without real understanding of the underlying pathophysiology. Recent advances now suggest that deficiency of a specific von Willebrand factor (VWF) cleaving protease promotes tissue injury in TTP.
Xinglong, Zheng   +2 more
openaire   +2 more sources

Transient TTP in childhood

Pediatric Blood & Cancer, 2009
AbstractThrombotic thrombocytopenic purpura (TTP) is a type of microangiopathic hemolytic anemia that is uncommon in childhood. Adults with TTP have a high mortality rate unless they are treated with plasma exchange. There are few reports of children with acquired idiopathic TTP, and most of those children received some form of treatment. We describe a
Naomi P, Moskowitz   +3 more
openaire   +2 more sources

Full-capped 12-S-atom TTP derivatives (BV-TTP, BE-TTP, EM-TTP and EV-TTP): syntheses, structures and charge transport properties

CrystEngComm, 2015
Highly π-conjugated multi-sulfur molecules are tightly packed forming single-component organic crystals with remarkable conductivity.
Qi Fang   +4 more
openaire   +1 more source

Race, rituximab, and relapse in TTP

Blood, 2022
Abstract Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black patients are overrepresented in iTTP cohorts in the United States, but racial disparities in iTTP outcome and response to therapy have not been studied.
Shruti Chaturvedi   +28 more
openaire   +2 more sources

TTP and pregnancy

Blood, 2014
In this issue of Blood, Jiang et al use the Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry to demonstrate that in women with a previous history of TTP, associated with severe ADAMTS13 deficiency, the frequency of TTP recurrence is low and pregnancy outcomes are positive ...
openaire   +2 more sources

TTP and pregnancy

British Journal of Haematology
SummaryAcute thrombocytopenic purpura (TTP) may present at any stage of pregnancy and the puerperium. Without prompt diagnosis and therapy, serious maternal and fetal outcomes may result. ADAMTS13 replacement via plasma exchange and immunosuppression are the mainstay of treatment.
P. Gounder, M. Scully
openaire   +2 more sources

Crystal Structures of TMEO-TTP and (TMEO-TTP)[AuBr2]·THF

Bulletin of the Chemical Society of Japan, 1994
Abstract The molecular and crystal structures of the title compounds, where TMEO-TTP is 2-[4,5-bis(methylthio)1,3-dithiol-2-ylidene]-5-[4,5-ethylenedioxy-1,3-dithiol-2-ylidene]-1,3,4,6-tetrathiapentalene, have been investigated by X-ray crystal structure analysis.
Yohji Misaki   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy